Zum Inhalt springen


The Atriva Management

Rainer Lichtenberger, Ph.D.,

30 years management in life science Industry, VP Global Marketing, Merck, EVP ratiopharm group for New Business. Since 16 years CEO experience in SME and biotech, raised € 80 Mn funds, involved in € 200+ Mn deal volume.

Read more

Stephan Stenglein, M.D.,
& EVP Clinical Development

Physician trained in Clinical and Molecular Virology with 20 years of accomplishments in pharma, medical device and vaccine development. Previous global management positions with Novartis and AstraZeneca.

Read more

Christian Wallasch, Ph.D., CDO/COO & EVP
Preclinical Development

20 years senior management experience (COO, CEO) in SMEs (Axxima, GPC Biotech and public companies (Intercel/Valneva)). Proven track record in the preclinical/clinical development of kinase inhibitors and vaccines, project-management and -execution.

Read more

Cees Stouten, M.Sc.,
SVP Chemistry Manufacturing Controls,
Site Manager Atriva Therapeutics BV 

Accomplished CMC manager with long-standing and deep experience along the entire development, manufacturing and control value chain,
more than 20 years industry experience

Read more

Björn Cochlovius, Ph.D.,
Assoc. Prof.
VP Business Development

20 years leadership positions in SMEs (Head R&D Affitech, CEO OnTarget) and global leadership positions in big pharma (Roche, Otsuka, Abbvie). Working experiences in Europe and Asia. Background in R&D, Business Development, M&A, Financing. Several Board seats and chairmanships.

Read more